8-K: Verano Holdings Reports Record Revenue for 2023, Achieves Positive Free Cash Flow

Sentiment:

Quarterly Report


Verano Holdings Corp. announced record revenue of $938 million for 2023 and a 16% increase in net cash provided by operating activities, reaching $110 million.

Summary

  • Verano Holdings Corp. reported its financial results for the fourth quarter and full year ended December 31, 2023.
  • The company achieved record revenue of $938 million for the full year, a 7% increase compared to 2022.
  • Net cash provided by operating activities increased by 16% to $110 million for the year.
  • Verano generated $73 million in free cash flow for 2023, meeting its guidance.
  • Fourth quarter revenue was $237 million, a 5% increase year-over-year but a 1% decrease compared to the previous quarter.
  • The company reported a net loss of $113 million for the full year and $73 million for the fourth quarter.
  • Adjusted EBITDA for the full year was $305 million, and $73 million for the fourth quarter.
  • The company's retail footprint expanded with new dispensaries in Florida, Connecticut, and Pennsylvania.
  • Verano has 138 dispensaries and 14 production facilities across 13 states.

Sentiment

Score: 7

Explanation: The document presents a generally positive outlook with record revenue and increased cash flow, but the net loss and first quarter guidance temper the overall sentiment. The company is well positioned for future growth, but faces some challenges.

Positives

  • The company achieved record revenue for the full year 2023.
  • Net cash from operating activities increased significantly year-over-year.
  • Verano generated positive free cash flow for the year.
  • Gross profit increased both for the quarter and the full year.
  • SG&A expenses decreased as a percentage of revenue for the full year.
  • The company expanded its retail footprint by opening new dispensaries.
  • Verano launched a new e-commerce platform for its Savvy brand.

Negatives

  • The company reported a net loss for both the fourth quarter and the full year.
  • Fourth quarter revenue decreased slightly compared to the previous quarter.
  • Gross profit decreased in the fourth quarter compared to the third quarter.
  • The company has a working capital deficit of $18 million.
  • Verano is forecasting a 5-7% revenue decline in the first quarter of 2024 compared to the prior year period.

Risks

  • The company faces potential challenges from the normalization of dispensary counts in New Jersey.
  • The company's working capital deficit could pose a financial risk.
  • The cannabis industry is subject to regulatory changes that could impact operations.
  • The company's future performance is subject to the risks described in its annual report on Form 10-K.

Future Outlook

The company expects a 5-7% revenue decline in the first quarter of 2024 compared to the prior year period due to the normalization of dispensary counts in New Jersey. Management believes 2024 has the potential to be a game-changing year with adult use imminent in Ohio, on the horizon in Florida and Pennsylvania, and the growing anticipation of a federal rescheduling decision.

Management Comments

  • I'm incredibly proud of our performance in 2023, highlighted by key wins across all aspects of the business, said George Archos, Verano Founder and Chief Executive Officer.
  • As excitement and anticipation builds in the industry, 2024 has the potential to be a game-changing year, and Verano is well positioned to continue capitalizing on growth opportunities both in the current regulatory environment and from any state or federal reform.
  • While we've never been dependent on legislation to drive sustained growth, with adult use imminent in Ohio, on the horizon in Florida and Pennsylvania, and the growing anticipation of a federal rescheduling decision, there is limitless potential for Verano.

Industry Context

The announcement comes as the cannabis industry anticipates potential regulatory changes, including adult-use legalization in several states and possible federal rescheduling. Verano's expansion and financial performance are being closely watched by investors and competitors in the sector.

Comparison to Industry Standards

  • Verano's revenue growth of 7% year-over-year is a solid performance in the cannabis industry, but it is important to compare this to other multi-state operators (MSOs) such as Curaleaf, Trulieve, and Green Thumb Industries.
  • Curaleaf, for example, reported revenue growth of 14% in their most recent quarter, while Trulieve reported a 12% increase, suggesting Verano's growth is slightly below the top performers.
  • Verano's adjusted EBITDA margin of 32% for the full year is competitive, but companies like Green Thumb Industries have reported higher margins, indicating potential areas for improvement.
  • The free cash flow of $73 million is a positive sign, but it is crucial to compare this to the capital expenditures and debt levels of other MSOs to assess overall financial health.
  • Verano's expansion into new markets and the launch of new brands are consistent with industry trends, but the success of these initiatives will determine their long-term impact.

Legal Proceedings

  • The company announced its participation in a coalition of industry stakeholders as a plaintiff challenging the legality of the federal government's intervention in legal intrastate cannabis commerce.

Stakeholder Impact

  • Shareholders will be interested in the company's revenue growth and profitability.
  • Employees may be impacted by the company's expansion and financial performance.
  • Customers will benefit from the company's expanded retail footprint and product offerings.
  • Suppliers will be impacted by the company's production and sales volumes.
  • Creditors will be interested in the company's debt levels and cash flow.

Next Steps

  • The company will hold a conference call and webcast on February 29, 2024, to discuss the results.
  • Verano will continue to expand its retail footprint and product offerings.
  • The company will monitor regulatory developments and pursue growth opportunities.

Key Dates

DateDescription
February 29, 2024Date of the press release announcing fourth quarter and full year 2023 financial results.
December 31, 2023End of the reporting period for the fourth quarter and full year 2023 financial results.

Keywords

cannabis, revenue, EBITDA, free cash flow, dispensaries, financial results, multi-state operator, retail, wholesale, Verano

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.